<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR660.html">Part 660
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 660.28  Labeling.
                            </h3>
                            <p class="depth0">In addition to the applicable labeling requirements of Sec. Sec.  610.62 through 610.65   and Sec. 809.10, and in lieu of the requirements in Sec. Sec. 610.60  and 610.61, the following requirements shall be met:</p><p class="depth0"><em>(a)</em> Final container label--(1) Color coding. The final container  label of all Blood Grouping Reagents shall be completely white, except  that all or a portion of the final container label of the following  Blood Grouping Reagents may be color coded with the specified color  which shall be a visual match to a specific color sample designated by  the Director, Center for Biologics Evaluation and Research. Printing on  all final container labels shall be in solid black. A logo or company  name may be placed on the final container label; however, the logo or  company name shall be located along the bottom or end of the label,  outside the main panel.  ------------------------------------------------------------------------</p><p class="depth0">Blood grouping reagent                Color of label paper ------------------------------------------------------------------------ Anti-A....................................  Blue. Anti-B....................................  Yellow. Slide and rapid tube test blood grouping</p><p class="depth0">reagents only:</p><p class="depth0">Anti-C..................................  Pink.</p><p class="depth0">Anti-D..................................  Gray.</p><p class="depth0">Anti-E..................................  Brown.</p><p class="depth0">Anti-CDE................................  Orange.</p><p class="depth0">Anti-c..................................  Lavender.</p><p class="depth0">Anti-e..................................  Green. ------------------------------------------------------------------------</p><p class="depth0"><em>(2)</em> Required information. The proper name ``Blood Grouping Reagent''  need not appear on the final container label provided the final  container is distributed in a package and the package label bears the  proper name. The final container label shall bear the following  information:</p><p class="depth0"><em>(i)</em> Name of the antibody or antibodies present as set forth in  paragraph (d) of this section.</p><p class="depth0"><em>(ii)</em> Name, address (including ZIP code), and license number of the  manufacturer.</p><p class="depth0"><em>(iii)</em> Lot number, including sublot designations.</p><p class="depth0"><em>(iv)</em> Expiration date.</p><p class="depth0"><em>(v)</em> Source of product if other than human plasma or serum.</p><p class="depth0"><em>(vi)</em> Test method(s) recommended.</p><p class="depth0"><em>(vii)</em> Recommended storage temperature in degrees Celsius.</p><p class="depth0"><em>(viii)</em> Volume of product if a liquid, or equivalent volume for a  dried product if it is to be reconstituted.</p><p class="depth0"><em>(ix)</em> If a dried product, to remind users to record the  reconstitution date on the label, the statement ``RECONSTITUTION DATE -- ------. EXPIRES 1 YEAR AFTER RECONSTITUTION DATE.''</p><p class="depth0"><em>(3)</em> Lettering size. The type size for the specificity of the  antibody designation on the labels of a final container with a capacity  of less than 5 milliliters shall be not less than 12 point. The type  size for the specificity of the antibody designations on the label of a  container with a capacity of 5 milliliters or more shall be not less  than 18 point.</p><p class="depth0"><em>(4)</em> Visual inspection. When the label has been affixed to the final  container, a sufficient area of the container shall remain uncovered for  its full length or no less than 5 millimeters of the lower circumference  to permit inspection of the contents. The label on a final product  container for antibodies Anti-c, Anti-k, or Anti-s shall display a bar  immediately over the specificity letter used in the name, i.e., Anti-c,  Anti-k, or Anti-s.</p><p class="depth0"><em>(b)</em> Package label. The following information shall appear either on  the package label or on the final container label if it is visible  within the package.</p><p class="depth0"><em>(1)</em> Proper name of the product.</p><p class="depth0"><em>(2)</em> Name of the antibody or antibodies present as set forth in  paragraph (d) of this section.</p><p class="depth0"><em>(3)</em> Name, address (including ZIP Code), and license number of the  manufacturer.</p><p class="depth0"><em>(4)</em> Lot number, including sublot designations.</p><p class="depth0"><em>(5)</em> Expiration date.</p><p class="depth0"><em>(6)</em> Preservative used and its concentration.</p><p class="depth0"><em>(7)</em> Number of containers, if more than one.</p><p class="depth0"><em>(8)</em> Volume or equivalent volume for dried products when  reconstituted, and precautions for adequate mixing when reconstituting.</p><p class="depth0"><em>(9)</em> Recommended storage temperature in degrees Celsius.</p><p class="depth0"><em>(10)</em> Source of the product if other than human serum or plasma.</p><p class="depth0"><em>(11)</em> Reference to enclosed package insert.</p><p class="depth0"><em>(12)</em> If a dried product, a statement indicating the period within  which the product may be used after reconstitution.</p><p class="depth0"><em>(13)</em> The statement: ``FOR IN VITRO DIAGNOSTIC USE.''</p><p class="depth0"><em>(14)</em> The statement: ``MEETS FDA POTENCY REQUIREMENTS.''</p><p class="depth0"><em>(15)</em> If human blood was used in manufacturing the product, the  statement: ``CAUTION: ALL BLOOD PRODUCTS SHOULD BE TREATED AS  POTENTIALLY INFECTIOUS. SOURCE MATERIAL FROM WHICH THIS PRODUCT WAS  DERIVED WAS FOUND NEGATIVE WHEN TESTED IN ACCORDANCE WITH CURRENT FDA  REQUIRED TESTS. NO KNOWN TEST METHODS CAN OFFER ASSURANCE THAT PRODUCTS  DERIVED FROM HUMAN BLOOD WILL NOT TRANSMIT INFECTIOUS AGENTS.''</p><p class="depth0"><em>(16)</em> A statement of an observable indication of an alteration of the  product, e.g., turbidity, color change, precipitate, that may indicate  possible deterioration of the product.</p><p class="depth0"><em>(c)</em> Package insert. Each final container of Blood Grouping Reagent  shall be accompanied by a package insert meeting the requirements of  Sec. 809.10. If two or more final containers requiring identical  package inserts are placed in a single package, only one package insert  per package is required.</p><p class="depth0"><em>(d)</em> Names of antibodies.</p><p class="depth0">Blood group designation for container label  Anti-A Anti-A1 Anti-A, B Anti-A and B Anti-B Anti-C Anti-C\w\ Anti-c Anti-CD Anti-CDE Anti-Co\b\ Anti-D Anti-DE Anti-Di\a\ Anti-E Anti-e Anti-Fy\a\ Anti-Fy\b\ Anti-I Anti-Jk\a\ Anti-Jk\b\ Anti-Js\a\ Anti-Js\b\ Anti-K Anti-k Anti-Kp\a\ Anti-Kp\b\ Anti-Le\a\ Anti-Le\b\ Anti-Lu\a\ Anti-Lu\b\ Anti-M Anti-M\g\ Anti-N Anti-P1 Anti-S Anti-s Anti-U Anti-Wr\a\ Anti-Xg\a\  [53 FR 12764, Apr. 19, 1988, as amended at 59 FR 23637, May 6, 1994; 67  FR 9587, Mar. 4, 2002; 70 FR 14985, Mar. 24, 2005]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
